9 results
PRE 14A
CCCC
C4 Therapeutics, Inc.
18 Apr 23
Preliminary proxy
7:59am
Fund, a venture philanthropy fund focused on early-stage research. From 1986 to 2006, Mr. Salter served as president of Mars & Co., a global strategy
DEF 14A
CCCC
C4 Therapeutics, Inc.
26 Apr 21
Definitive proxy
4:22pm
-founder of the Dana-Farber Innovations Research Fund, a venture philanthropy fund focused on early-stage research. Mr. Cohen was co-founder and served … -founder of the Dana-Farber Innovations Research Fund, a venture philanthropy fund focused on early-stage research. From 1986 to 2006, Mr. Salter served
424B4
nyoqu4j32lq69fuoa
2 Oct 20
Prospectus supplement with pricing info
5:10pm
S-1/A
453cysj58 d9ubyh8
28 Sep 20
IPO registration (amended)
6:07am
S-1
2waegfjxocdu4kpsiy
10 Sep 20
IPO registration
5:26pm
DRS
k9ffr7de4x6
6 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next